Sector pending / Pharmaceutical PreparationsUpdated 2026-05-10 22:07 UTC

BVL/BMYUS stock hub

BVL/BMYUS has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

BVL/BMYUSis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

394.9B

Lima Stock Exchange

Market data

Price

Recent price action with selectable time range.

BVL/BMYUSBVL/BMYUS

—

Loading chart…

In the news

Latest news · BVL/BMYUS

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E9.1

P25 n/aP50 n/aP75 n/a

Trailing P/E15.5

P25 n/aP50 n/aP75 n/a

ROE38.7

P25 n/aP50 n/aP75 n/a

ROIC20.9

P25 n/aP50 n/aP75 n/a

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All BVL/BMYUS market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

208

Groups with data

Currency

USD

Showing 208 of 208 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	United States
Country code	PE
Employees	32,500
Employees Change	-1,600%
Employees Change Percent	-4.69
Enterprise value	$517.5B
Exchange	Lima Stock Exchange
Financial currency	USD
First seen	2026-05-10
Industry	Pharmaceutical Preparations
Last refreshed	2026-05-10
Market cap	$394.9B
Price	$57.78
Price currency	USD
Rev Per Employee	5,207,563.5x
Sic	2834
Symbol	bvl/BMYUS
Website	https://www.bms.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	6.43%
EV Earnings	20.38x
EV/EBIT	9.77x
EV/EBITDA	7.75x
EV/FCF	12.45x
EV/Sales	3.1x
FCF yield	10.53%
Forward P/E	9.08x
P/B ratio	5.63x
P/E ratio	15.55x
P/S ratio	2.33x
PE Ratio10 Y	39.48x
PE Ratio3 Y	16.73x
PE Ratio5 Y	19.37x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	31.56%
EBITDA Margin	39.14%
FCF margin	24.56%
Gross margin	71.98%
Gross Profit	$121.8B
Gross Profit Growth	-1.91%
Gross Profit Growth Q	-1.25%
Gross Profit Growth3 Y	-1.01%
Gross Profit Growth5 Y	0.44%
Net Income	$25.4B
Net Income Growth	34.25%
Net Income Growth Q	9%
Net Income Growth3 Y	-0.16%
Pretax Margin	19.79%
Profit Margin	15.01%
Profit Per Employee	$781,425
ROA	10.69
Roa5y	6.51
ROCE	22.73
ROE	38.73
Roe5y	13.18
ROIC	20.88
Roic5y	14.63

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	28.05%
Cagr3y	-3.01%
Cagr5y	1.85%
Div CAGR3	0.46%
Div CAGR5	4.85%
EPS Growth	33.74
EPS Growth Q	9.17
EPS Growth3 Y	1.37
FCF Growth	-9%
FCF Growth Q	-55.31%
FCF Growth3 Y	2.43%
FCF Growth5 Y	-2.04%
OCF Growth	-7.02%
OCF Growth Q	-43.5%
OCF Growth10 Y	29.83%
OCF Growth3 Y	2.87%
OCF Growth5 Y	-0.93%
Revenue Growth	1.78x
Revenue Growth Q	2.57x
Revenue Growth3 Y	1.88x
Revenue Growth5 Y	2.52x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.54
Assets	$301.9B
Cash	$36.6B
Current Assets	$93.8B
Current Liabilities	$66B
Debt	$162.1B
Debt EBITDA	$2.4
Debt Equity	$2.31
Debt FCF	$3.9
Equity	$70.2B
Interest Coverage	8.48
Liabilities	$231.7B
Long Term Assets	$208.1B
Long Term Liabilities	$165.7B
Net Cash	$-124.2B
Net Cash By Market Cap	$-31.45
Net Debt EBITDA	$1.88
Net Debt Equity	$1.77
Net Debt FCF	$2.99
Tangible Book Value	$-69.5B
Tangible Book Value Per Share	$-34.05

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.42
Inventory Turnover	5.01
Net Working Capital	$247.9M
Quick ratio	1.18
Working Capital	$28.1B
Working Capital Turnover	$22.93

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-0.47%
Dividend Growth	-5.45%
Dividend Growth Years	4%
Dividend per share	$8.64
Dividend Years	7
Dividend Yield	14.95%
Ex Div Date	2026-04-02
Last Dividend	$2.18
Payout Frequency	Quarterly
Payout Ratio	69.69%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	28.03%
200-day SMA	50.01
3Y total return	-8.77%
50-day SMA	55.71
50-day SMA vs 200-day SMA	50over200
5Y total return	9.59%
All Time High	72.7
All Time High Change	-20.52%
All Time High Date	2022-12-28
All Time Low	40.1
All Time Low Change	44.09%
All Time Low Date	2024-07-08
ATR	0.13
Ch YTD	7.28
High52	59.03
High52 Date	2026-04-22
High52ch	-2.12%
Low52	43.5
Low52 Date	2025-11-25
Low52ch	32.83%
Ma50ch	3.71%
Price vs 200-day SMA	15.53%
RSI	60.28
RSI Monthly	57.94
RSI Weekly	76.22
Sharpe ratio	1.06x
Sortino ratio	3.28
Total Return	14.48%
Tr YTD	9.85
Tr1m	-2.12%
Tr3m	10.2%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	$53.4B
Operating Income Growth	38.03
Operating Income Growth Q	7.35
Operating Income Growth3 Y	16.68
Operating Income Growth5 Y	15.03
Operating margin	31.56

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	2,038,886,888%
Net Borrowing	-19,716,581,500
Shares Insiders	0.05%
Shares Institutions	81.98%
Shares Qo Q	0.29%
Shares Yo Y	0.47%
Short Ratio	2.69

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$39.6B
Average Volume	5x
Bv Per Share	34.31
CAPEX	$-4.9B
Ch1m	-2.12
Ch1y	21.64
Ch3m	8.9
Ch3y	-20.52
Ch5y	-10.42
Ch6m	32.83
Change	0%
Close	57.78
Depreciation Amortization	12,663,131,250
Earnings Date	2026-04-30
EBIT	$53.4B
EBITDA	$66.2B
EPS	$12.47
F Score	7
FCF	$41.6B
FCF EV Yield	8.03x
Financing CF	-38,103,173,500
Fiscal Year End	December
Founded	1,887
Goodwill	74,910,605,000
Graham Number	29.30183
Graham Upside	-49.29
Income Tax	$8.1B
Investing CF	-13,139,747,600
Is Primary Listing	0
Last Earnings Date	2026-04-30
Last Report Date	2026-03-31
Lynch Fair Value	$18.58
Lynch Upside	-67.84
Ma150	51.21
Ma150ch	12.82%
Ma20	58.5
Ma20ch	-1.23%
Net CF	-4,510,242,800
P FCF Ratio	9.5
P OCF Ratio	8.5
Payment Date	2026-05-01
Ppne	31,652,659,500
Price Date	2026-05-08
Price EBITDA	$5.96
Revenue	169,245,813,800x
SBC By Revenue	1.14x
Share Based Comp	1,937,449,500
Tax By Revenue	4.79x
Tax Rate	24.22%
Tr6m	36.02%
Z Score	2.48

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

BVL/BMYUS dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+14.9%

$8.64 annual per share

Payout ratio

+69.7%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

+4.8%

4 consecutive years of growth

Total shareholder yield

+14.5%

Next ex-dividend date: 2026-04-02

Performance

BVL/BMYUS stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns BVL/BMYUS?

Insider, institutional, and short-interest positioning.

Institutional ownership

+82.0%

Share of float held by funds and institutions

Insider ownership

+0.1%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

BVL/BMYUS momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

60.3

Neutral momentum band

Price vs 200-day MA

+15.5%

50/200-day relationship not available

Beta (5Y)

n/a

Sensitivity to the broader market

Sharpe ratio

1.06

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About BVL/BMYUS

Hub-level FAQ points readers to the deeper analysis pages.

What is the current bvl/BMYUS stock rating?

bvl/BMYUS is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full bvl/BMYUS analysis?

The full report lives at /stocks/bvl/BMYUS/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for bvl/BMYUS?

The latest report frames bvl/BMYUS around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the bvl/BMYUS page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.